Form 8-K - Current report:
SEC Accession No. 0001213900-20-002349
Filing Date
2020-02-03
Accepted
2020-02-03 08:38:26
Documents
2
Period of Report
2020-01-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k013120_citiuspharma.htm 8-K 30255
2 PRESS RELEASE DATED FEBRUARY 3, 2020 f8k013120ex99-1_citiuspharma.htm EX-99.1 7753
  Complete submission text file 0001213900-20-002349.txt   39382
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20567069
SIC: 2834 Pharmaceutical Preparations